Antiretroviral therapy. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

CD4-Positive T-Lymphocytes Plasma CD8-Positive T-Lymphocytes Leukocytes, Mononuclear T-Lymphocyte Subsets Cerebrospinal Fluid Semen T-Lymphocytes

Organisms7

HIV-1 HIV Proviruses HIV-2 Simian immunodeficiency virus Macaca mulatta GB virus C

Diseases36

HIV Infections Acquired Immunodeficiency Syndrome AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome HIV Seropositivity Immune Reconstitution Inflammatory Syndrome Viremia Pregnancy Complications, Infectious AIDS Dementia Complex Coinfection Lymphoma, AIDS-Related Cytomegalovirus Retinitis Lipodystrophy Tuberculosis HIV Wasting Syndrome Disease Progression AIDS-Associated Nephropathy Acidosis, Lactic Sarcoma, Kaposi Substance Abuse, Intravenous Hepatitis C Meningitis, Cryptococcal Toxoplasmosis, Cerebral Pneumonia, Pneumocystis Simian Acquired Immunodeficiency Syndrome Leukoencephalopathy, Progressive Multifocal Dyslipidemias Tuberculosis, Pulmonary Drug-Induced Liver Injury Substance-Related Disorders Mycobacterium avium-intracellulare Infection Anus Neoplasms Candidiasis, Oral Mouth Diseases Hepatitis B Immune System Diseases

Chemicals and Drugs53

Anti-HIV Agents Anti-Retroviral Agents Reverse Transcriptase Inhibitors HIV Protease Inhibitors RNA, Viral Stavudine Zidovudine Nevirapine Benzoxazines Ritonavir Lopinavir Lamivudine Organophosphonates Indinavir Adenine Pyrimidinones Didanosine Nelfinavir HIV Reverse Transcriptase Dideoxynucleosides Oxazines HIV Protease Antitubercular Agents Saquinavir Antiviral Agents pol Gene Products, Human Immunodeficiency Virus DNA, Viral Pyrrolidinones Protease Inhibitors Trimethoprim-Sulfamethoxazole Combination HIV Integrase Inhibitors Biological Markers Cyclohexanes HIV Fusion Inhibitors Receptors, CCR5 Drugs, Generic Drug Combinations HIV Antibodies AIDS Vaccines HIV Core Protein p24 Integrase Inhibitors Methadone Antigens, CD38 Drugs, Investigational Gene Products, pol Nucleosides Zalcitabine Neopterin Carbamates Pyridines gag Gene Products, Human Immunodeficiency Virus Alanine Transaminase HIV Antigens

Analytical, Diagnostic and Therapeutic Techniques and Equipment50

Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Viral Load Drug Therapy, Combination Cohort Studies Treatment Outcome Treatment Failure Lost to Follow-Up Drug Monitoring Directly Observed Therapy Drug Administration Schedule Prospective Studies Risk Factors Retrospective Studies Cross-Sectional Studies Follow-Up Studies Prevalence CD4-CD8 Ratio Incidence Longitudinal Studies Withholding Treatment Lymphocyte Count Multivariate Analysis Proportional Hazards Models Chemoprevention Logistic Models Survival Analysis Kaplan-Meier Estimate Pilot Projects Life Expectancy Lymphocyte Activation Case-Control Studies Epidemiologic Methods Regression Analysis Clinical Trials as Topic Sequence Analysis, DNA Drug Substitution Statistics, Nonparametric Models, Statistical Questionnaires Antibiotic Prophylaxis Flow Cytometry Confidence Intervals Randomized Controlled Trials as Topic Odds Ratio AIDS Serodiagnosis Polymerase Chain Reaction Models, Theoretical Sensitivity and Specificity Linear Models

Psychiatry and Psychology15

Medication Adherence Patient Compliance AIDS Dementia Complex Treatment Refusal Substance Abuse, Intravenous Homosexuality, Male Sexual Behavior Social Stigma Substance-Related Disorders Risk-Taking Counseling Heterosexuality HIV Serosorting Stereotyping Health Knowledge, Attitudes, Practice

Phenomena and Processes25

CD4 Lymphocyte Count Viral Load Drug Resistance, Viral Drug Resistance, Multiple, Viral Time Factors Virus Replication CD4-CD8 Ratio Pregnancy Lymphocyte Count HIV Seronegativity Virus Latency Genotype Drug Interactions Viral Tropism Mutation Genes, pol Virus Shedding Homosexuality, Male Lymphocyte Activation Mutation, Missense Phylogeny Heterosexuality Odds Ratio Sensitivity and Specificity Virus Activation

Anthropology, Education, Sociology and Social Phenomena6

Developing Countries Treatment Refusal Socioeconomic Factors Prisons Developed Countries Demography

Information Science6

Prevalence Incidence Life Expectancy Phylogeny Questionnaires Molecular Sequence Data

Named Groups6

HIV Long-Term Survivors Infant, Newborn Drug Users Patient Dropouts Prisoners Sexual Partners

Health Care61

Medication Adherence Infectious Disease Transmission, Vertical Cohort Studies Patient Compliance Treatment Outcome Treatment Failure Prospective Studies Risk Factors Retrospective Studies Cross-Sectional Studies Follow-Up Studies Prevalence Incidence Longitudinal Studies Treatment Refusal Withholding Treatment Multivariate Analysis Proportional Hazards Models Health Services Accessibility Logistic Models Health Resources Survival Analysis Ambulatory Care Facilities Kaplan-Meier Estimate World Health Organization Rural Population Pilot Projects Life Expectancy Socioeconomic Factors Cost-Benefit Analysis Drug Costs Epidemics Case-Control Studies Epidemiologic Methods Regression Analysis Delivery of Health Care Clinical Trials as Topic Age Factors Drug Substitution Statistics, Nonparametric Eligibility Determination Disease Transmission, Infectious Counseling Sex Factors Models, Statistical Questionnaires National Health Programs Confidence Intervals Health Care Costs Randomized Controlled Trials as Topic Health Facilities World Health Odds Ratio Comorbidity Health Knowledge, Attitudes, Practice Standard of Care Sensitivity and Specificity Patient Acceptance of Health Care Demography Urban Population Linear Models

Geographicals35

South Africa Uganda Botswana Malawi Africa South of the Sahara Zambia Cote d'Ivoire Africa, Southern Zimbabwe Haiti Cameroon Thailand Kenya Lesotho Rwanda Cambodia British Columbia Brazil Tanzania United States Mozambique India Africa San Francisco Ethiopia Togo Asia Africa, Western Nigeria Africa, Eastern France Switzerland Namibia Latin America Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Antiretroviral Therapy, Highly Active HIV Infections Anti-HIV Agents Anti-Retroviral Agents CD4 Lymphocyte Count Viral Load HIV-1 HIV Acquired Immunodeficiency Syndrome Reverse Transcriptase Inhibitors Drug Resistance, Viral HIV Protease Inhibitors AIDS-Related Opportunistic Infections South Africa Medication Adherence RNA, Viral Stavudine Zidovudine Nevirapine Benzoxazines Infectious Disease Transmission, Vertical Drug Therapy, Combination Cohort Studies HIV-Associated Lipodystrophy Syndrome Ritonavir HIV Seropositivity Patient Compliance Immune Reconstitution Inflammatory Syndrome Uganda Viremia Lopinavir Lamivudine Organophosphonates CD4-Positive T-Lymphocytes Treatment Outcome Treatment Failure Pregnancy Complications, Infectious Indinavir Lost to Follow-Up Drug Resistance, Multiple, Viral AIDS Dementia Complex Botswana Malawi Adenine Pyrimidinones Didanosine Coinfection Lymphoma, AIDS-Related Nelfinavir Drug Monitoring Directly Observed Therapy Drug Administration Schedule HIV Reverse Transcriptase Prospective Studies Africa South of the Sahara Zambia Dideoxynucleosides Cote d'Ivoire Cytomegalovirus Retinitis Risk Factors Africa, Southern Time Factors Retrospective Studies Lipodystrophy Cross-Sectional Studies Oxazines Tuberculosis HIV Wasting Syndrome HIV Protease Disease Progression Antitubercular Agents Follow-Up Studies Developing Countries Zimbabwe Prevalence Virus Replication Plasma AIDS-Associated Nephropathy CD4-CD8 Ratio Saquinavir Incidence Longitudinal Studies HIV Long-Term Survivors CD8-Positive T-Lymphocytes Haiti Pregnancy Cameroon Antiviral Agents pol Gene Products, Human Immunodeficiency Virus Treatment Refusal Acidosis, Lactic Thailand Withholding Treatment Sarcoma, Kaposi Kenya Lesotho Lymphocyte Count HIV Seronegativity Virus Latency Substance Abuse, Intravenous

No FAQ available that match "antiretroviral therapy"